BRIM Biotechnology Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 32

Employees

  • Stock Symbol
  • 6885

Stock Symbol

  • Share Price
  • $0.75
  • (As of Friday Closing)

BRIM Biotechnology General Information

Description

BRIM Biotechnology Inc is engaged in the research and development of new drug translation, genetic testing services, research and development services in natural and engineering sciences, and medical laboratory services. The Group has two reportable operating segments: BRIM's main business is new drug translational development services, and Compass's main business is gene sequencing and testing technology services. It generates the majority of its revenue from the BRIM segment. Geographically, it operates in Taiwan, Japan, and the USA. It generates the majority of its revenue from Taiwan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 8th Floor, No. 1, Alley 30
  • Lane 358, Ruiguang Road, Neihu District
  • Taipei, 114-92
  • Taiwan
+886 02
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TAI
Vertical(s)
Corporate Office
  • 8th Floor, No. 1, Alley 30
  • Lane 358, Ruiguang Road, Neihu District
  • Taipei, 114-92
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BRIM Biotechnology Stock Performance

As of 20-Nov-2026, BRIM Biotechnology’s stock price is $0.75. Its current market cap is $100M with 133M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.75 $0.80 $0.62 - $1.08 $100M 133M 949K -$0.11

BRIM Biotechnology Financials Summary

As of 30-Sep-2026, BRIM Biotechnology has a trailing 12-month revenue of $397K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 105,525 88,746 79,482 89,381
Revenue 397 176 10 3
EBITDA (14,485) (14,075) (10,565) (22,610)
Net Income (13,947) (13,991) (9,831) (22,089)
Total Assets 49,713 58,444 73,307 57,884
Total Debt 243 510 236 117
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BRIM Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BRIM Biotechnology‘s full profile, request access.

Request a free trial

BRIM Biotechnology Patents

BRIM Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4777077-A1 Ophthalmic composition Pending 28-Aug-2023
JP-2025532327-A Composition containing pedf-derived short peptides and mesenchymal stem cells for bone and cartilage regeneration Pending 05-Oct-2022
AU-2023356324-A1 Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration Pending 05-Oct-2022
EP-4598560-A1 Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration Pending 05-Oct-2022
EP-4598560-A4 Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration Pending 05-Oct-2022 A61K38/55
To view BRIM Biotechnology’s complete patent history, request access »

BRIM Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BRIM Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BRIM Biotechnology‘s full profile, request access.

Request a free trial

BRIM Biotechnology ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view BRIM Biotechnology’s complete esg history, request access »

BRIM Biotechnology FAQs

  • When was BRIM Biotechnology founded?

    BRIM Biotechnology was founded in 2013.

  • Where is BRIM Biotechnology headquartered?

    BRIM Biotechnology is headquartered in Taipei, Taiwan.

  • What is the size of BRIM Biotechnology?

    BRIM Biotechnology has 32 total employees.

  • What industry is BRIM Biotechnology in?

    BRIM Biotechnology’s primary industry is Biotechnology.

  • Is BRIM Biotechnology a private or public company?

    BRIM Biotechnology is a Public company.

  • What is BRIM Biotechnology’s stock symbol?

    The ticker symbol for BRIM Biotechnology is 6885.

  • What is the current stock price of BRIM Biotechnology?

    As of 20-Nov-2026 the stock price of BRIM Biotechnology is $0.75.

  • What is the current market cap of BRIM Biotechnology?

    The current market capitalization of BRIM Biotechnology is $100M.

  • What is BRIM Biotechnology’s current revenue?

    The trailing twelve month revenue for BRIM Biotechnology is $397K.

  • What is BRIM Biotechnology’s annual earnings per share (EPS)?

    BRIM Biotechnology’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process